Zobrazeno 1 - 10
of 298
pro vyhledávání: '"Morris A Blajchman"'
Publikováno v:
PLoS Medicine, Vol 3, Iss 10, p e472; author reply e471 (2006)
Externí odkaz:
https://doaj.org/article/46609c37f0994bf39d476a7905ebc6dd
Publikováno v:
Revista da Sociedade Brasileira de Medicina Tropical, Vol 29, Iss 1, Pp 47-49 (1996)
The present measures adopted to prevent transfusion-associated Chagas' disease include screening of blood donors. and/or the inactivation of T. cruzi in collected blood using gentian violet (GV) as a trypanocidal agent. In this study, we investigated
Externí odkaz:
https://doaj.org/article/a136948fdff24ecb9c7373008d010599
Autor:
Steven R. Sloan, Morris A. Blajchman, Robert Hunsaker, Susan F. Assmann, Jerrold H. Levy, Cassandra D. Josephson, Charles T. Klodell, Marie E. Steiner, Paul M. Ness, Rhonda Cooke, Janice G. McFarland, Kathleen E. Puca, Ravindra Karanam, Thomas J. Raife, Darrell J. Triulzi, Thomas L. Ortel, Glenn J.R. Whitman, Suzanne Granger, Larissa Bornikova, Ronald Miles, Meghan Delaney, Yara A. Park, Samuel Youssef, Cornelius M. Dyke, Richard M. Kaufman, Eldad A. Hod, Arthur W. Bracey, Jeffrey L. Carson, Melissa M. Cushing, Gregory A. Nuttall, Elliott Bennett-Guerrero, Lynne Uhl, Shelley Pulkrabek, Christopher P. Stowell, Pamela D'Andrea, Pamela R. Roberts, Jeffrey McCullough, Richard M. Engelman, Vincent A. Scavo, Pampee P. Young, Philip E. Greilich
Publikováno v:
New England Journal of Medicine. 372:1419-1429
Some observational studies have reported that transfusion of red-cell units that have been stored for more than 2 to 3 weeks is associated with serious, even fatal, adverse events. Patients undergoing cardiac surgery may be especially vulnerable to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9a537c828d6d314009b916ba0182383
https://doi.org/10.1056/nejmoa1414219
https://doi.org/10.1056/nejmoa1414219
Publikováno v:
Transfusion. 53:221-231
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cd38beeea1525959469555a88bbe22f
https://doi.org/10.1111/j.1537-2995.2012.03708.x
https://doi.org/10.1111/j.1537-2995.2012.03708.x
Autor:
Jacques Lacroix, Salim Yusuf, Jeffrey L. Carson, Barbara C. Tilley, Traci Heath Mondoro, Richard Platt, Darrell J. Triulzi, Elizabeth L. Wagner, John W. Eikelboom, Nancy M. Heddle, Andrew J. Vickers, Michael S. Lauer, Simone A. Glynn, Morris A. Blajchman
Publikováno v:
Transfusion. 52:1363-1378
Comparative effectiveness research (CER) is the study of existing treatments or ways to deliver health care to determine what intervention works best under specific circumstances. CER evaluates evidence from existing studies or generates new evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87b75fce4beca13947ad75a196eff7d3
https://doi.org/10.1111/j.1537-2995.2012.03640.x
https://doi.org/10.1111/j.1537-2995.2012.03640.x
Publikováno v:
American Journal of Hematology. 87:235-238
Clinical trials in hemostasis and thrombosis (HT) are needed to guide medical practice and future research. Providing public support for trials that could have the greatest impact on clinical care has been a major challenge. The National Heart, Lung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::845f9b135233111cc1441473fa7649e6
https://doi.org/10.1002/ajh.22225
https://doi.org/10.1002/ajh.22225
Publikováno v:
Transfusion. 51:828-841
BACKGROUND: In September 2009, the National Heart, Lung, and Blood Institute convened the State-of-the-Science Symposium in Transfusion Medicine to identify Phase II and/or III clinical trials that would provide important information to advance trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d3023ca0267d9696cf6cf7389928d8a
https://doi.org/10.1111/j.1537-2995.2010.02898.x
https://doi.org/10.1111/j.1537-2995.2010.02898.x
Publikováno v:
Transfusion Medicine Reviews. 24:259-285
The use of blood products to support patients undergoing the large variety of medical and surgical interventions requiring such support has continued to escalate very significantly over time. Relevantly, significant practice variation in the use of b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76992fa60022a7c7bcd0ea7b8464341c
https://doi.org/10.1016/j.tmrv.2010.05.002
https://doi.org/10.1016/j.tmrv.2010.05.002
Publikováno v:
Transfusion Medicine Reviews
After reviewing the relative frequency of the causes of allogeneic blood transfusion-related mortality in the United States today, we present 6 possible strategies for further reducing such transfusion-related mortality. These are (1) avoidance of un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1bf7c1a0e8e659a41485aef9bb96918
http://europepmc.org/articles/PMC7126657
http://europepmc.org/articles/PMC7126657